BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

Overview

patients om metformin from diabetic clinic were checked for bladder cancer

Full Title of Study: “BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Screening
    • Masking: Single (Participant)
  • Study Primary Completion Date: January 2014

Interventions

  • Other: metformin

Arms, Groups and Cohorts

  • Placebo Comparator: metformin
    • metformin 500mg
  • No Intervention: not on metformin

Clinical Trial Outcome Measures

Primary Measures

  • Number of diabetic patients on metformin therapy
    • Time Frame: 6 months

Participating in This Clinical Trial

Inclusion Criteria

  • 150 people attending diabetic clinic Exclusion Criteria:

Gender Eligibility: All

Minimum Age: 25 Years

Maximum Age: 86 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • UFUOMA MILLER FAKPOR
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: UFUOMA MILLER FAKPOR, miss – University of Cape Coast

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.